Mar 22, 2022 (MarketNewsVideo.com via COMTEX) --
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Thursday, PureCycle Technologies' Director, Jeffrey Richard Fieler, made a $5M buy of PCT, purchasing 714,284 shares at a cost of $7.00 each. So far Fieler is in the green, up about 33.3% on their buy based on today's trading high of $9.33. PureCycle Technologies is trading up about 2.9% on the day Tuesday. This buy marks the first one filed by Fieler in the past twelve months.
And on Monday, Director Thilo Schroeder purchased $3.43M worth of Revolution Medicines, purchasing 168,051 shares at a cost of $20.40 a piece. Before this latest buy, Schroeder purchased RVMD at 3 other times during the past year, for a total investment of $34.17M at an average of $24.80 per share. Revolution Medicines is trading up about 11.9% on the day Tuesday. So far Schroeder is in the green, up about 14.2% on their purchase based on today's trading high of $23.31.
The preceding is a transcript of the MarketNewsVideo.com video published at: https://www.marketnewsvideo.com/?id=20220320220322insiderPCTRV&mv=1 .
COMTEX_404588874/2478/2022-03-22T11:14:15
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.
